文献速递主动脉疾病

开放转换与半转换治疗血管内动脉瘤修复术后迟发性内漏的多中心比较

Multicenter comparison between open conversions and semi-conversions for late endoleaks after endovascular aneurysm repair.
PubMed 文献 · J Vasc Surg · 2022-01-24

该多中心研究比较了血管内动脉瘤修复术后迟发性开放转换(完全或部分移除内移植物)与半转换(保留内移植物)的早期和随访结局。结果显示半转换组术后并发症率更低,但中期生存率显著劣于开放转换组,且内漏持续或复发率高,降低了半转换的耐久性。

要点

  • 半转换组术后并发症率低于开放转换组(29.2% vs 45.5%,P = .04)。
  • 开放转换组30天死亡率为12.2%,半转换组为10.4%(P = .73)。
  • 半转换组5年估计生存率低于开放转换组(37% vs 64%,log-rank P = .01)。

核心结论

  • 半转换在减少术后并发症方面优于开放转换,但中期生存率显著较差;持续和/或复发性内漏的高发生率降低了半转换的耐久性。

研究设计与样本

  • 多中心比较研究,纳入1997年至2020年间11个血管中心的所有迟发性开放转换(LOC,完全或部分移除内移植物)和半转换(SC,保留内移植物),排除内移植物感染或血栓形成。
  • 共347例患者因血管内动脉瘤修复并发症接受手术,其中270例因内漏手术(LOC 222例,SC 48例)。
  • 主要终点为早期死亡率和长期生存估计;次要终点为术后并发症率和随访期间转换相关并发症的差异。

主要发现

  • LOC组平均年龄75 ± 8岁,SC组79 ± 7岁(P = .009);两组美国麻醉医师协会评分(LOC 3.2 ± 0.7 vs SC 3 ± 0.5,P = .128)和主要内移植物特征(肾上固定、分叉/主髂动脉单侧构型)均衡。
  • LOC指征:I型内漏62.2%(138/222),II型内漏21.6%(48/222),III型内漏7.7%(17/222),内张力8.5%(19/222);SC指征:II型内漏64.6%(31/48),I型内漏33.3%(16/48),III型内漏2.1%(1/48)。
  • 30天死亡率LOC组12.2%(27/222),SC组10.4%(5/48)(P = .73);术后并发症率LOC组高于SC组(45.5% vs 29.2%;P = .04)。
  • LOC后估计生存率1年80%、5年64%;SC后1年72%、5年37%(log-rank P = .01)。
  • 中位随访21.5个月(四分位距2.4-61个月)期间,SC组38.3%发现内漏,27.7%记录到瘤囊增长。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study is to compare early and follow-up outcomes of late open conversions (LOC, with complete or partial endograft explantation) and semi-conversions (SC, with endograft preservation) after endovascular aneurysm repair in a multicenter experience. METHODS: All LOC and SC performed from 1997 to 2020 in 11 vascular centers were compared. Endograft infections or thrombosis were excluded. Primary endpoints were early mortality and long-term survival estimates. Secondary endpoints were differences in postoperative complication rates and conversion-related complications during follow-up. RESULTS: In the considered period, 347 patients underwent surgery for endovascular aneurysm repair complications. Among these, 270 were operated on for endoleaks (222 LOC, 48 SC). The two groups were homogeneous in terms of American Society of Anesthesiologists score (LOC, 3.2 ± 0.7; SC, 3 ± 0.5; P = .128) and main endograft characteristics (suprarenal fixation, bifurcated/aorto-uni-iliac configuration). The mean age was 75 ± 8 years for LOC and 79 ± 7 years for SC (P = .009). Reasons for LOC were: 62.2% (138/222) type I endoleak, 21.6% (48/222) type II endoleak, 7.7% (17/222) type III endoleak, and 8.5% (19/222) endotension. Indications for SC were: 64.6% (31/48) type II endoleak, 33.3% (16/48) type I endoleak, and 2.1% (1/48) type III endoleak. Thirty-day mortality was 12.2% (27/222) in the LOC group, and 10.4% (5/48) in the SC group (P = .73). Postoperative complication rate was higher in the LOC group (45.5% vs 29.2%; P = .04). The estimated survival rate after LOC was 80% at 1 year and 64% at 5 years; after SC, it was 72% at 1 year and 37% at 5 years (log-rank P = .01). During the median follow-up of 21.5 months (interquartile range, 2.4-61 months), an endoleak after SC was found in the 38.3% of the cases; sac growth was recorded in the 27.7% of SC patients. CONCLUSIONS: SC has an early benefit over LOC in terms of reduced postoperative complications but has a significantly inferior mid-term survival. The high rates of persistent and/or recurrent endoleaks reduce SC durability.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Perini P, Gargiulo M, Silingardi R, et al. Multicenter comparison between open conversions and semi-conversions for late endoleaks after endovascular aneurysm repair. J Vasc Surg. 2022. PMID: 35085746. doi:10.1016/j.jvs.2022.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。